Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To assess if the addition of oral veliparib to carboplatin and paclitaxel compared to carboplatin and paclitaxel alone in subjects with metastatic or advanced NSCLC will improve progression-free survival (PFS).
Inclusion criteria
- Metastatic or Advanced Non-Small-Cell Lung Cancer (NSCLC)